Skip to main content

Table 1 Patient characteristics

From: Palliative radiotherapy near the end of life

Variable Median (IQR) or % (n, of 518)  
Age at diagnosis 60 (50–68)  
Percent female 46% (238)  
Race  
 White 66% (340)  
 East Asian 14% (74)  
 African American 8.7% (45)  
 Southeast Asian 3.7% (19)  
 Asian NOS 3.7% (19)  
 Other (includes American Indian, Pacific Islander) 4.1% (21)  
Percent Hispanic 9.1% (47)  
Survival time since diagnosis (months) 28 (11–53)  
Primary diagnosis  
 Lung 26% (137)  
 Breast 19% (97)  
 Prostate 9.7% (50)  
 Renal cell 5.8% (30)  
 Colorectal 5.8% (30)  
 Hepatocellular 3.8% (20)  
 Head and Neck 3.5% (18)  
 Skin 3.3% (17)  
 Othera 23% (119)  
Metastatic at diagnosis 49% (254)  
Site of metastases  
 Brain 47% (244)  
 Lung 55% (284)  
 Liver 40% (208)  
Bone only 17% (90)  
BMI last course 24(21–27)  
KPS last consult 60 (50–80)  
 KPS > 70 45% (231/511)  
Hospitalization within 3 months of RT consult 58% (289/500)  
TEACHH scoreb   Median survival, months (IQR)
 0–1 (Group A) 6.2% (32/450) 6 (2.8–11)
 2–4 (Group B) 68% (352/450) 2.2 (1.0–5.0)
 5–6 (Group C) 13% (66/450) 1.3 (0.5–2.3)
CHOW groupb
 I 18% (92/510) 4.7 (2–11)
 II 44% (227/510) 2.5 (1.0–5.6)
 III 37% (191/510) 1.6 (0.7–2.7)
Hospice involved  
 Yes 47% (245)  
 No 28% (147)  
 Unknown 24% (126)  
Place of death  
 Inpatient, acute care 23% (120)  
 Home 29% (151)  
 Inpatient hospice, non-acute care 10% (52)  
 SNF (not hospice) 1.5% (8)  
 Unknown 36% (187)  
  1. aIncludes primary cancer of the liver, bile ducts, esophagus, ovary, pancreas, meninges, endometrium, anus, lymph nodes, CNS, and pleura
  2. bSome patients had incomplete information and thus TEACHH or Chow groups could not be calculated (denominators 450 and 510 respectively). Performance status at RT consult was the most commonly missing information, but also hospitalizations within 3 months of RT consult and number of prior palliative chemotherapy courses